Connecting over shared experiences
If you or a loved one lives with schizophrenia, you know how difficult the day-to-day can be. The symptoms, the stigma, and the isolation can feel overwhelming. Food expert, TV host, and author Gail Simmons knows this too well and invites you to the table to talk about it.
By sharing her family’s experience with schizophrenia, Gail and her special guests open up about the highs, lows, and resilience that connect them. In these conversations, they reflect on the importance of finding the right treatment—like COBENFY™ (xanomeline and trospium chloride)—together with the support of community.
Pull up a chair and be part of the conversation.
I wanted to be part of this campaign because my older brother, Alan, lived with schizophrenia. My family knows firsthand the struggles, so it’s important to let people living with schizophrenia and their families know that treatments like COBENFY, together with support, can make a difference.
—Gail Simmons
Alan was not treated with COBENFY.
Individual results may vary.
Real experiences: The importance of connection
Avary is sharing his individual experiences. Results may vary.
Avary and Ashleigh:
Leaning on each other
Avary and his wife and care partner, Ashleigh, speak candidly about their experiences with Avary’s schizophrenia diagnosis, his journey in finding COBENFY, and how leaning on each other has helped them along the way.
Chanel is sharing her individual experiences. Results may vary.
Chanel and Fines:
An unbreakable bond
Through trust, compassion, and the overall improvement in symptoms* that COBENFY can provide, Chanel and her mother and care partner, Fines, share the inspiring bond they’ve created as they face the ups and downs of schizophrenia side by side.
*COBENFY was studied in two 5-week clinical studies with 470 adults with schizophrenia aged 18 to 65 who either took COBENFY or a sugar pill. A rating scale measured changes in symptoms overall, including positive, negative, and general psychopathology symptoms. Individual results may vary.
The most common side effects of COBENFY include nausea, stomach upset or burning (dyspepsia), constipation, vomiting, high blood pressure, stomach (abdominal) pain, diarrhea, increased heart rate, dizziness, and heartburn (gastrointestinal reflux disease).
Please see additional Important Safety Information below.
Want to learn more about COBENFY?
Be your own advocate
Dr Patricia Ares-Romero discusses why it’s so important to establish a connection with your provider and to speak up about all of your symptoms to help get the proper diagnosis and find a treatment that is right for you.
Dr Ares-Romero was compensated for her time.
Interested in talking to your healthcare provider about COBENFY?
It’s very easy to be isolated and withdrawn when you’re struggling with schizophrenia, which is why support is so important for patients. Having supportive family, friends, and providers can be vital to having a successful treatment journey.
—Dr Patricia Ares-Romero, Board-Certified Psychiatrist
Discover what makes COBENFY different†
†COBENFY is a combination of a muscarinic agonist (xanomeline) and a muscarinic antagonist (trospium chloride).
Learn about the efficacy of COBENFY
See more experiences of people living with schizophrenia